Daniel Vitt

Founder of Immunic Therapeutics

Daniel Vitt

Backed by

Sources

Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company — 2026-02

Browse all founders · Browse investors